FDA approves new gene therapy for immune disorder

FDA approves new gene therapy for immune disorder

FDA approves new gene therapy for immune disorder | The Jerusalem PostJerusalem Post/Health & WellnessGene therapy uses the patient’s own blood stem cells, which were genetically modified to include functional copies of the WAS gene, the FDA…

Continue Reading